ClinicalTrials.Veeva

Menu

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization. (SARC-ICU)

H

Hospital Mutua de Terrassa

Status

Invitation-only

Conditions

Critical Illness
Ultrasound Evaluation
Body Composition Measurement
Sarcopenia
Bio-Impedance Measurements
Intensive Care (ICU) Myopathy

Study type

Observational

Funder types

Other

Identifiers

NCT07303335
P/25-054/Fundació assistencial
Mutua Terrassa (Other Identifier)

Details and patient eligibility

About

This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older than 18 years old.
  • Expected duration of mechanical ventilation (MV) exceeding 48 hours.

Exclusion criteria

  • Refusal to participate.
  • Mechanical ventilation not exceeding 48 hours.
  • Do-not-resuscitate (DNR) orders or limitations of therapeutic effort upon admission.

Trial design

100 participants in 1 patient group

Critically ill adults (medical or surgical) expected to require prolonged mechanical ventilation.
Description:
Assesment of the body composition using Rectus Femoris (RF) Ultrasound and Bioelectrical Impedance Analysis (BIA)

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems